Danaher (DHR) stock trades ~5% lower as the company, with its Q4 2024 results, projects a sales contraction in the current ...
Stifel analysts reduced the price target for Danaher Corporation shares (NYSE:DHR) to $260 from the previous target of $265, while maintaining a Hold rating on the stock. The new target sits within ...
Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in ...
Barclays lowered the firm’s price target on Danaher (DHR) to $240 from $275 and keeps an Equal Weight rating on the shares. The company ...
U.S. stocks slipped after the Federal Reserve held its main interest rate steady and broke a run of cuts that began in ...
Danaher Corporation DHR reported weaker-than-expected fourth-quarter earnings on Wednesday. The company reported fourth-quarter adjusted earnings per share of $2.14 missing the street view of $2.16.
This positive outcome has rippled through the industry, with Danaher and Thermo Fisher anticipating their own earnings reports later this week. Analysts have weighed in on Sartorius's results, ...
Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Beckman Coulter Diagnostics, ...
In a report released today, Brandon Couillard from Wells Fargo maintained a Hold rating on Danaher (DHR – Research Report), with a price target ...